Posted September 10, 2014

Seller of Joint Pain Supplement Warned for Drug Claims

On August 24, 2014, the FDA issued a warning letter to CreAgri, Inc., following a website review, which found statements made about the company's products, including Olivenol plus Easeflex, Olivenol plus Essence Capsules, and Olivenol plus Essence Elixer, to be drug claims.

Olivenol plus Easeflex contains olives (Olea europaea) and glucosamine hydrochloride. It was promoted for joint pain and inflammation with statements such as "Helps in production and repair of cartilage," and "proven to help in cases of severe joint disorders like chronic arthritis and osteoarthritis."

Olivenol plus Essence Capsules and Olivenol plus Essence Elixer contain olives (Olea europaea). They were promoted for joint and skin diseases, with statements such as "proven to help in cases of chronic systemic inflammations affecting skin, joints and internal organs," and "[P]roven to help in cases of severe skin disorders like psoriasis, eczema, allergic dermatitis, etc."

See ConsumerLab.com's Review of Joint Health Supplements for tests of related products.

See Related Warnings:

Seller of "Nerve", "Cleanse" and Probiotic Supplements Warned for Drug Claims

Seller of Immune Supplement Warned for Drug Claims

Seller of Joint Supplement Warned for Manufacturing Violations and Drug Claims

Seller of Mineral and Joint Supplements Warned for Manufacturing Violations and Drug Claims

Vita Springs Health Warned for Manufacturing Violations and Drug Claims

Seller of Flaxseed, Ginkgo and More Warned for Manufacturing Violations and Drug Claims

Seller of Aloe, Thyroid and Other Supplements Warned for Manufacturing Violations and Drug Claims

Herbal Supplement Company Warned For Drug Claims, Manufacturing Violations

Maker of Digestive Health Supplement Warned For Manufacturing Violations, Drug Claims

To read the FDA's warning, use the link below.